Clinical, Pathological, and Molecular Characteristics in Colorectal Cancer

doi:10.3390/books978-3-0365-6836-2

Download Url(s)

https://mdpi.com/books/pdfview/book/6931

Contributor(s)

Dedieu, Stephane (editor)

Language

English

Show full item record

Abstract

Despite major medical advances in recent decades, colorectal cancer remains a major public health problem with significant unmet medical needs. This reprint presents new scientific and clinical data, and discusses the need to identify new theranostic biomarkers from tissue and fluid biopsies, to go further in terms of personalised medicine and thus overcome current limitations.

URI

https://directory.doabooks.org/handle/20.500.12854/98878

Keywords

Snail transcription factor; extracellular vesicles; colon cancer; pre-metastatic niche; PD-L1; CMS; RAS mutations; colorectal cancer; liver metastases; surgery; resection; ablation; discoidin domain receptor; prognosis; event free survival; survival; chemokine; ACKR3; metastasis; microenvironment; signaling pathways; epigenetics; therapy; resistance; lung metastases; protein biomarker; dual expression; early recurrence; poor prognosis; precision medicine; ERBB2; HER-2; Lynch Syndrome; mismatch repair proteins; genome-wide association study; Mendelian randomization; polygenic risk scores; liquid biopsy; rare cell; circulating tumor cells; oncosomes; heterogeneity; multi-assay; high-definition single-cell assay; colonic neoplasms; chemotherapy; adjuvant; tumor budding; n/a